Literature DB >> 18406140

The parvovirus capsid odyssey: from the cell surface to the nucleus.

Carole E Harbison1, John A Chiorini, Colin R Parrish.   

Abstract

During cellular entry and infection, the parvovirus capsid follows a complex path from the cell surface to the nucleus, where the DNA is replicated. Various receptors have been characterized that bind to different parvoviruses and mediate their entry into cells. However, the subsequent trafficking pathways within the endosomal system, cytoplasm and into the nucleus are still not well defined. Studies of viruses entering various cell types under different conditions show particles located in many different endosomal compartments, within the cytoplasm and in the nucleus with significant variations in timing and distribution. Here, we define the previously unresolved issues that are now better understood for the infection pathways of these viruses, and outline some of the areas that remain to be clarified in future studies.

Mesh:

Year:  2008        PMID: 18406140     DOI: 10.1016/j.tim.2008.01.012

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  35 in total

1.  Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.

Authors:  R Sayroo; D Nolasco; Z Yin; Y Colon-Cortes; M Pandya; C Ling; G Aslanidi
Journal:  Gene Ther       Date:  2015-10-08       Impact factor: 5.250

2.  Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle.

Authors:  Susan F Cotmore; Susan Hafenstein; Peter Tattersall
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

3.  Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.

Authors:  Blake H Albright; Katherine E Simon; Minakshi Pillai; Garth W Devlin; Aravind Asokan
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

4.  Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.

Authors:  Heather M Callaway; Kurtis H Feng; Donald W Lee; Andrew B Allison; Melissa Pinard; Robert McKenna; Mavis Agbandje-McKenna; Susan Hafenstein; Colin R Parrish
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle.

Authors:  Sarah Cohen; Alexandra K Marr; Pierre Garcin; Nelly Panté
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

6.  Structure of an enteric pathogen, bovine parvovirus.

Authors:  Shweta Kailasan; Sujata Halder; Brittney Gurda; Heather Bladek; Paul R Chipman; Robert McKenna; Kevin Brown; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

7.  Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid.

Authors:  Jonas Löfling; Sangbom Michael Lyi; Colin R Parrish; Ajit Varki
Journal:  Virology       Date:  2013-03-14       Impact factor: 3.616

8.  Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.

Authors:  Melodie L Weller; Panomwat Amornphimoltham; Michael Schmidt; Paul A Wilson; J Silvio Gutkind; John A Chiorini
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

9.  BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96.

Authors:  Giovanni Di Pasquale; Nikola Kaludov; Mavis Agbandje-McKenna; John A Chiorini
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

10.  Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus.

Authors:  Agnès Vendeville; Marc Ravallec; Françoise-Xavière Jousset; Micheline Devise; Doriane Mutuel; Miguel López-Ferber; Philippe Fournier; Thierry Dupressoir; Mylène Ogliastro
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.